Indian scientists divided over restricted use approval for Covaxin
In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement…
Category: DCGI
Vaccine dilemma: To take or not to take Covaxin
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…
I would not take Covaxin without efficacy data: Gagandeep Kang
Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…
With hasty approval, India squanders an opportunity to build trust in COVID-19 vaccine
Transparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take the vaccine. If there is already some degree of anxiety…
By putting the vaccine approval on hold for want of data, DCGI has underscored its priorities
The greatly reassuring decision to seek additional safety and immunogenicity data from the Pune-based Serum Institute of India and Hyderabad’s Bharat Biotech underlines the regulator’s priorities even for emergency use…
Transparency in COVID-19 vaccine trials vital to gain public trust
Unlike Pfizer, AstraZeneca, which is carrying out the phase-3 trials of the Oxford vaccine in four countries, is yet to secure a nod from any of the regulatory agencies despite…
‘Serum’s pneumococcal vaccine will be available by June 2020’
Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet to be approved by the DCGI. But phase-3 trial data…
WHO prequalifies Serum’s low-cost pneumococcal vaccine
WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia in Latin America, Africa and Asia. The vaccine will cost…
